, Author at GEN - Genetic Engineering and Biotechnology News

genprowebdirectory

GEN Edge
- Featured News
- Multimedia
News
- Insights
Topics
Magazine
Multimedia
- Summits
- Webinars
- GEN Live
- Learning Labs
- Podcasts
Resources
Subscribe
- Get GEN Magazine
- Get GEN eNewsletters

Search

Sign in

Welcome! Log into your account

your username

your password

Forgot your password? Get help

Password recovery

Recover your password

your email

A password will be e-mailed to you.

GEN – Genetic Engineering and Biotechnology News

GEN Edge
- Featured News
- Multimedia
News
- Insights
Topics
Magazine
Multimedia
- Summits
- Webinars
- GEN Live
- Learning Labs
- Podcasts
Resources
Subscribe
- Get GEN Magazine
- Get GEN eNewsletters

Home Authors Posts by

37597 POSTS 0 COMMENTS

Jarret Glasscock, PhD, is CEO of Cofactor Genomics.

No posts to display

Recently Featured

Brooks Instrument Joins Regenerative Drug Manufacturing Consortium

Brooks Instrument Joins Regenerative Drug Manufacturing Consortium

Massive Reference Genome Project Characterizes Primate Variation

Massive Reference Genome Project Characterizes Primate Variation

Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial

Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial

Potential Therapeutic Target for Chronic Kidney Disease Uncovered

Potential Therapeutic Target for Chronic Kidney Disease Uncovered

Read the Digital Edition

Explore

About GEN
Contact GEN
GEN Staff
Editorial Guidelines
Reprints and Permissions
Scientific Advisory Board

Advertise

Media Kit and Planning Calendar
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
List Rental
Advertising Terms and Conditions

Resources

Get the GEN Magazine
Get the GEN Email Newsletter
Inside Precision Medicine
Privacy Policy

Home
Terms of Service
Privacy Policy
Cookie Policy
Mary Ann Liebert, Inc.

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.

Scroll Up